Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-019-03007-w.pdf
Reference28 articles.
1. Breiman L, Friedman J, Olshen R et al (1984) Classification and regression trees. Routledge, Abingdon
2. Castellucci P, Fuccio C, Fanti S (2010) Reply: influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med 51:499–500
3. De Bruycker A, Lambert B, Claeys T et al (2017) Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy. BJU Int 120:815–821
4. Decaestecker K, De Meerleer G, Lambert B (2014) Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence. Radiat Oncol 9(1):135
5. Ferlay J, Colombet M, Soeriomataram I et al (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144(8):1941–1953
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The oligometastatic paradigm and the role of radiotherapy;Clinical Medicine;2023-01
2. A critical review on oligometastatic disease: a radiation oncologist’s perspective;Medical Oncology;2022-09-07
3. Survival Analysis and a Novel Nomogram Model for Progression-Free Survival in Patients with Prostate Cancer;Journal of Oncology;2022-03-22
4. Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer;Cancer Management and Research;2021-09
5. Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?;Urologic Oncology: Seminars and Original Investigations;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3